Editorial: Personalized medicine for neuromuscular disorders
Marc Bartoli,
Rachel M. Bailey,
Rachel M. Bailey,
Kathrin Meyer,
Kathrin Meyer,
Florian Barthélémy,
Florian Barthélémy
Affiliations
Marc Bartoli
Institut national de la santé et de la recherche médicale, Marseille Medical Genetics, U1251, Aix Marseille University, Marseille, France
Rachel M. Bailey
Division of Child Neurology, Department of Pediatrics, University of Texas Southwestern, Dallas, TX, United States
Rachel M. Bailey
Center for Alzheimer’s and Neurodegenerative Diseases, University of Texas Southwestern, Dallas, TX, United States
Kathrin Meyer
Center for Gene Therapy, Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, OH, United States
Kathrin Meyer
Department of Pediatrics, The Ohio State University, Columbus, OH, United States
Florian Barthélémy
Center for Duchenne Muscular Dystrophy at UCLA, Los Angeles, CA, United States
Florian Barthélémy
Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine, College of Letters and Sciences, University of California, Los Angeles, Los Angeles, CA, United States
